Clinical trial
A Pilot Pharmacokinetic Phase I Evaluation of BI-RG-587 in HIV-Infected Children
NCT00000634 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00000634 |
|---|---|
| Title | A Pilot Pharmacokinetic Phase I Evaluation of BI-RG-587 in HIV-Infected Children |
| Official title | A Pilot Pharmacokinetic Phase I Evaluation of BI-RG-587 in HIV-Infected Children |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Boehringer Ingelheim Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Nevirapine |
| Enrollment | 6 |
| Primary completion | Jun 1, 1995 |
| First posted | Aug 31, 2001 |
| Last update posted | Mar 1, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: